[(2R,5R)-5-[4-(2-hydroxypropan-2-yl)pyrazol-1-yl]-2-methylpiperidin-1-yl]-(2-propan-2-yloxyphenyl)methanone
C22H31N3O3 — CID 121314185
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R,5R)-5-[4-(2-hydroxypropan-2-yl)pyrazol-1-yl]-2-methylpiperidin-1-yl]-(2-propan-2-yloxyphenyl)methanone
[(2R,5R)-5-[4-(2-hydroxypropan-2-yl)pyrazol-1-yl]-2-methylpiperidin-1-yl]-(2-propan-2-yloxyphenyl)methanone (PubChem CID 121314185) has the molecular formula C22H31N3O3 and a molecular weight of 385.51 g/mol. Its IUPAC name is [(2R,5R)-5-[4-(2-hydroxypropan-2-yl)pyrazol-1-yl]-2-methylpiperidin-1-yl]-(2-propan-2-yloxyphenyl)methanone.
Molecular Properties
| Compound Name | [(2R,5R)-5-[4-(2-hydroxypropan-2-yl)pyrazol-1-yl]-2-methylpiperidin-1-yl]-(2-propan-2-yloxyphenyl)methanone |
|---|---|
| PubChem CID | 121314185 |
| Molecular Formula | C22H31N3O3 |
| Molecular Weight | 385.51 g/mol |
| Exact Mass | 385.24 |
| IUPAC Name | [(2R,5R)-5-[4-(2-hydroxypropan-2-yl)pyrazol-1-yl]-2-methylpiperidin-1-yl]-(2-propan-2-yloxyphenyl)methanone |
| SMILES | CC(C)Oc1ccccc1C(=O)N1C[C@H](n2cc(C(C)(C)O)cn2)CC[C@H]1C |
| InChI | InChI=1S/C22H31N3O3/c1-15(2)28-20-9-7-6-8-19(20)21(26)24-14-18(11-10-16(24)3)25-13-17(12-23-25)22(4,5)27/h6-9,12-13,15-16,18,27H,10-11,14H2,1-5H3/t16-,18-/m1/s1 |
| InChIKey | OWCYJZWTIPTKSG-SJLPKXTDSA-N |
| XLogP | 3.76 |
| TPSA | 67.59 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.51 |
| LogP ≤ 5 | 3.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121314185 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.